Drug Trial Radar · NCT00001034
The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV
Last checked: Nov 20, 2026Latest source record: Nov 4, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
850
Actual
Start
Not stated
Primary completion
Not stated
Study completion Aug 1995
Sponsor
- Sponsor type
- NIH
- Collaborators
- Hoffmann-La Roche
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Phase 2
- Model
- Parallel
- Primary purpose
- Treatment
- Who can join
- All sexes, from 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and efficacy of oral ganciclovir for prophylaxis against cytomegalovirus (CMV) retinal and gastrointestinal mucosal disease in HIV-infected patients with severe immunosuppression. The most recent treatments against CMV disease have been ganciclovir and foscarnet. Until recently, both drugs required intravenous administration. An oral form of ganciclovir, if shown to be effective therapy against CMV, would be a more suitable method of administration for prophylaxis.
Conditions
- Cytomegalovirus Retinitis
- HIV Infections
- Gastrointestinal Diseases
Interventions
GanciclovirDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Community Consortium of San Francisco
San Francisco, California
Denver CPCRA / Denver Public Hlth
Denver, Colorado
Wilmington Hosp / Med Ctr of Delaware
Wilmington, Delaware
Veterans Administration Med Ctr / Regional AIDS Program
Washington D.C., District of Columbia
AIDS Research Consortium of Atlanta
Atlanta, Georgia
AIDS Research Alliance - Chicago
Chicago, Illinois
Louisiana Comm AIDS Rsch Prog / Tulane Univ Med
New Orleans, Louisiana
Comprehensive AIDS Alliance of Detroit
Detroit, Michigan
Henry Ford Hosp
Detroit, Michigan
Schering - Plough Corp
Kenilworth, New Jersey
North Jersey Community Research Initiative
Newark, New Jersey
Addiction Research and Treatment Corp
Brooklyn, New York
Clinical Directors Network of Region II
New York, New York
Harlem AIDS Treatment Group / Harlem Hosp Ctr
New York, New York
Bronx Lebanon Hosp Ctr
The Bronx, New York
Portland Veterans Adm Med Ctr / Rsch & Education Grp
Portland, Oregon
Richmond AIDS Consortium
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.